Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-01-05 @ 10:31 PM
Study NCT ID:
NCT00268593
Status:
COMPLETED
Last Update Posted:
2011-06-15
First Post:
2005-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
Sponsor:
Progen Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PR88206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Darryn Bampton
Old Organization:
Progen Pharmaceuticals